Attenuated	attenuated	O	O	O	O
disruption	disruption	O	O	O	O
of	of	O	O	O	O
prepulse	prepulse	O	O	O	O
inhibition	inhibition	O	O	O	O
by	by	O	O	O	O
dopaminergic	dopaminergic	O	O	O	O
stimulation	stimulation	O	O	O	O
after	after	O	O	O	O
maternal	maternal	O	O	O	O
deprivation	deprivation	O	O	O	O
and	and	O	O	O	O
adolescent	adolescent	O	O	O	O
corticosterone	corticosterone	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
in	in	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
development	development	O	O	O	O
of	of	O	O	O	O
schizophrenia	schizophrenia	O	DISEASE	OTHERS	I
may	may	O	O	O	O
include	include	O	O	O	O
an	an	O	O	O	O
early	early	O	O	O	O
neurodevelopmental	neurodevelopmental	O	O	O	O
stress	stress	O	O	O	O
component	component	O	O	O	O
which	which	O	O	O	O
increases	increases	O	O	O	O
vulnerability	vulnerability	O	O	O	O
to	to	O	O	O	O
later	later	O	O	O	O
stressful	stressful	O	O	O	O
life	life	O	O	O	O
events	events	O	O	O	O
,	,	O	O	O	O
in	in	O	O	O	O
combination	combination	O	O	O	O
leading	leading	O	O	O	O
to	to	O	O	O	O
overt	overt	O	O	O	O
disease	disease	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
investigated	investigated	O	O	O	O
the	the	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
an	an	O	O	O	O
early	early	O	O	O	O
stress	stress	O	O	O	O
,	,	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
form	form	O	O	O	O
of	of	O	O	O	O
maternal	maternal	O	O	O	O
deprivation	deprivation	O	O	O	O
,	,	O	O	O	O
combined	combined	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
later	later	O	O	O	O
stress	stress	O	O	O	O
,	,	O	O	O	O
simulated	simulated	O	O	O	O
by	by	O	O	O	O
chronic	chronic	O	O	O	O
periadolescent	periadolescent	O	O	O	O
corticosterone	corticosterone	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
,	,	O	O	O	O
on	on	O	O	O	O
behaviour	behaviour	O	O	O	O
in	in	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

Acute	acute	O	O	O	O
treatment	treatment	O	O	O	O
with	with	O	O	O	O
apomorphine	apomorphine	CHEMICALS	O	OTHERS	I
caused	caused	O	O	O	O
disruption	disruption	O	O	O	O
of	of	O	O	O	O
prepulse	prepulse	O	O	O	O
inhibition	inhibition	O	O	O	O
(	(	O	O	O	O
PPI	ppi	O	O	O	O
)	)	O	O	O	O
in	in	O	O	O	O
controls	controls	O	O	O	O
and	and	O	O	O	O
in	in	O	O	O	O
rats	rats	O	O	O	O
that	that	O	O	O	O
had	had	O	O	O	O
undergone	undergone	O	O	O	O
either	either	O	O	O	O
maternal	maternal	O	O	O	O
deprivation	deprivation	O	O	O	O
or	or	O	O	O	O
corticosterone	corticosterone	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
,	,	O	O	O	O
but	but	O	O	O	O
was	was	O	O	O	O
surprisingly	surprisingly	O	O	O	O
absent	absent	O	O	O	O
in	in	O	O	O	O
rats	rats	O	O	O	O
that	that	O	O	O	O
had	had	O	O	O	O
undergone	undergone	O	O	O	O
the	the	O	O	O	O
combined	combined	O	O	O	O
early	early	O	O	O	O
and	and	O	O	O	O
late	late	O	O	O	O
stress	stress	O	O	O	O
.	.	O	O	O	O

Amphetamine	amphetamine	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
significantly	significantly	O	O	O	O
disrupted	disrupted	O	O	O	O
PPI	ppi	O	O	O	O
in	in	O	O	O	O
both	both	O	O	O	O
non-deprived	non-deprived	O	O	O	O
groups	groups	O	O	O	O
,	,	O	O	O	O
but	but	O	O	O	O
was	was	O	O	O	O
absent	absent	O	O	O	O
in	in	O	O	O	O
both	both	O	O	O	O
maternally	maternally	O	O	O	O
deprived	deprived	O	O	O	O
groups	groups	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
serotonin-1A	serotonin-1a	O	O	O	O
receptor	receptor	O	O	O	O
agonist	agonist	O	O	O	O
,	,	O	O	O	O
8-OH-DPAT	8-oh-dpat	O	O	O	O
,	,	O	O	O	O
induced	induced	O	O	O	O
a	a	O	O	O	O
significant	significant	O	O	O	O
disruption	disruption	O	O	O	O
of	of	O	O	O	O
PPI	ppi	O	O	O	O
in	in	O	O	O	O
all	all	O	O	O	O
groups	groups	O	O	O	O
.	.	O	O	O	O

Amphetamine-induced	amphetamine-induced	O	O	O	O
locomotor	locomotor	O	DISEASE	OTHERS	I
hyperactivity	hyperactivity	O	DISEASE	OTHERS	I
was	was	O	O	O	O
similar	similar	O	O	O	O
in	in	O	O	O	O
all	all	O	O	O	O
groups	groups	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
results	results	O	O	O	O
show	show	O	O	O	O
an	an	O	O	O	O
inhibitory	inhibitory	O	O	O	O
interaction	interaction	O	O	O	O
of	of	O	O	O	O
early	early	O	O	O	O
stress	stress	O	O	O	O
,	,	O	O	O	O
caused	caused	O	O	O	O
by	by	O	O	O	O
maternal	maternal	O	O	O	O
deprivation	deprivation	O	O	O	O
,	,	O	O	O	O
combined	combined	O	O	O	O
with	with	O	O	O	O
'	'	O	O	O	O
adolescent	adolescent	O	O	O	O
'	'	O	O	O	O
stress	stress	O	O	O	O
,	,	O	O	O	O
simulated	simulated	O	O	O	O
by	by	O	O	O	O
corticosterone	corticosterone	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
,	,	O	O	O	O
on	on	O	O	O	O
dopaminergic	dopaminergic	O	O	O	O
regulation	regulation	O	O	O	O
of	of	O	O	O	O
PPI	ppi	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
altered	altered	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
apomorphine	apomorphine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
amphetamine	amphetamine	CHEMICALS	O	OTHERS	I
could	could	O	O	O	O
indicate	indicate	O	O	O	O
differential	differential	O	O	O	O
changes	changes	O	O	O	O
in	in	O	O	O	O
dopamine	dopamine	CHEMICALS	O	OTHERS	I
receptor	receptor	O	O	O	O
signalling	signalling	O	O	O	O
leading	leading	O	O	O	O
to	to	O	O	O	O
functional	functional	O	O	O	O
desensitisation	desensitisation	O	O	O	O
,	,	O	O	O	O
or	or	O	O	O	O
altered	altered	O	O	O	O
modulation	modulation	O	O	O	O
of	of	O	O	O	O
sensory	sensory	O	O	O	O
gating	gating	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
nucleus	nucleus	O	O	O	O
accumbens	accumbens	O	O	O	O
by	by	O	O	O	O
limbic	limbic	O	O	O	O
structures	structures	O	O	O	O
such	such	O	O	O	O
as	as	O	O	O	O
the	the	O	O	O	O
hippocampus	hippocampus	O	O	O	O
.	.	O	O	O	O

